In the first talcum powder trial to take place since the COVID-19 pandemic shuttered courthouses, an Illinois jury came back July 30 with a defense verdict. Three talc trials followed, in Pennsylvania, Missouri and Georgia, and all the juries sided with Johnson & Johnson.

The string of losses is a marked departure for attorneys representing ovarian cancer victims, who, although they haven’t won every time, have collected awards of tens of millions, even $4.7 billion, prior to the pandemic.